Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Detecting the Ancient Genetic Parasite
Neurology Genetics and epigenetics Precision medicine Technology and innovation Research and Innovations Molecular Pathology

Detecting the Ancient Genetic Parasite

Electronic genome mapping opens a window to enzymatic attack on DNA, linked to cancer, age-related decline, and neurodegenerative disease

04/10/2026 Interview 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Report: Detecting the Ancient Genetic Parasite

Overview

This report discusses the use of electronic genome mapping (EGM) to directly detect DNA-damaging activity of the LINE-1 retrotransposon, which has implications for understanding age-related diseases. The findings highlight the potential for EGM to enhance early diagnosis and treatment strategies for conditions such as cancer and neurodegeneration.

Background

The LINE-1 retrotransposon is a significant contributor to genomic instability and has been linked to various age-related diseases. Understanding its activity is crucial for developing novel diagnostic and therapeutic approaches. Recent advancements in genome mapping technologies, such as EGM, provide new insights into the mechanisms of DNA damage and mutation.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • EGM allows for genome-wide mapping of LINE-1 endonuclease activity.
  • LINE-1 is implicated in DNA damage and mutation, contributing to cancer and neurodegenerative diseases.
  • EGM can detect structural variants (SVs) in the human genome with high resolution.
  • Understanding LINE-1 activity may lead to new strategies for early diagnosis and treatment of age-related diseases.
  • EGM addresses challenges in mapping endonuclease-induced DNA nicks within complex mixtures.

Clinical Implications

The ability to map LINE-1 activity genome-wide could enhance the understanding of its role in disease processes, potentially leading to improved diagnostic tools and therapeutic strategies. Clinicians may consider the implications of LINE-1 activity in the context of age-related diseases and genomic instability.

Conclusion

The advancements in EGM technology represent a significant step forward in understanding the impact of ancient genetic parasites like LINE-1 on human health. This knowledge could pave the way for innovative approaches to diagnosing and treating age-related diseases.

References

  1. BioSpace, Direct Genome-Scale Mapping of Endonuclease Activity of the Human LINE-1 ORF2p Endonuclease
  2. The Journal of Infectious Diseases, Rapid High-Sensitivity Detection of Antibodies to Trypanosoma cruzi With a Recombinant Tc24 Antigen-Based Magneto-Immunoassay: A Pilot Study
  3. Open Forum Infectious Diseases, Increase in the Prevalence of the Plasmodium falciparum Kelch13 R622I Variant in Northwest Ethiopia
  4. Frontiers in Immunology, Time-resolved transcriptomics of haemocyte discrimination between challenges by nematodes and inert material in the oriental armyworm Mythimna separata
  5. Alzheimer's Association Workgroup Publishes Biology-Based Criteria for Diagnosis and Staging of Alzheimer's Disease
  6. The Journal of Infectious Diseases — Rare Mutant Isoforms of PfCRT in Plasmodium falciparum Linked to Piperaquine Resistance in Africa Carry Significant Fitness Costs
  7. Direct Genome-Scale Mapping of Endonuclease Activity of the Human LINE-1 ORF2p Endonuclease - BioSpace
  8. Alzheimer's Association Workgroup Publishes Biology-Based Criteria for Diagnosis and Staging of Alzheimer's Disease
  9. Study Details | NCT05193994 | Triumeq in Amyotrophic Lateral Sclerosis | ClinicalTrials.gov

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.